Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 45Lung Neoplasms 28Neoplasms 26Colorectal Neoplasms 20Prostatic Neoplasms 14Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Fatigue 9Anxiety Disorders 8Neoplasm Metastasis 7Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Papillomavirus Infections 6Ovarian Neoplasms 5Multiple Myeloma 5Melanoma 5Head and Neck Neoplasms 5Gastrointestinal Neoplasms 5Depression 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Breast Carcinoma In Situ 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3

Interventions

Ultrasonic Waves 1Tobacco Use Cessation Devices 1Therapeutics 1Nicotine Replacement Therapy 1Nicotine Chewing Gum 1Focus Groups 1Ethanol 1Educational Status 1Dosage Forms 1Cognitive Behavioral Therapy 1Behavior Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Substance-Related Disorders × Educational Status × Clear all
NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡